| VITROLIFE AB SK 0,2 |
| Schweden |
| Gesundheit |
| SE0011205202 / A2JLT3 |
| VTFN (Frankfurt) |
| FRA:VTFN, ETR:VTFN, VTFN:GR |
| - |
| https://www.vitrolife.com.. |
|
Vitrolife AB is a leading global provider of medical devices and genetic testing services dedicated to the reproductive-health market, specializing in assisted reproduction technologies. The company develops, manufactures, and distributes specialized..
>Volltext.. |
| 1343.47 Mio. EUR |
| 1407.06 Mio. EUR |
| 308.23 Mio. EUR |
| 92.45 Mio. EUR |
| -453.74 Mio. EUR |
| -3.35 EUR |
| 143.25 Mio. EUR |
| 80.23 Mio. EUR |
| - |
| 1.5 |
| -6.34% |
| -1097.18% |
| 0.1 EUR |
| 1.02% |
| 1.04% |
| 06.05.26 - 0.100815006€ 30.04.25 - 0.099451005€ >weitere anzeigen... |
| - |
| VITROLIFE |
| 22.05.26 |
|
||||
|